Effect of pentagastrin and gastrin-17 on the secretory function of the gastric glands
https://doi.org/10.31146/1682-8658-ecg-195-11-75-78
Abstract
The regulation of the digestive glands of the stomach and pancreas in the body of animals and humans is provided by peptides, most of which are in various molecular forms. 10 molecular forms of peptides of the gastrin group and 5 peptides of the cholecystokinin (CCK) group have been identified, containing in their structure from 4 to 56 amino acids, the physiological role of which has been little studied. It has been proven that the liver removes up to 85% of short-chain peptides of the gastrin (pentagastrin) and cholecystokinin (CCK-8) groups.
About the Authors
M. A. Zhuraeva
Andijan State Medical Institute (ASMI)
Uzbekistan
Uzbekistan
Mohigul A. Zhuraeva, MD, Professor of RAE, Associate Professor of the Department of GP-1 Medical Faculty
Andijan, 170127, Atabekov str., 1
V. A. Aleynik
Andijan State Medical Institute (ASMI)
Uzbekistan
Uzbekistan
Vladimir A. Aleynik, MD, Professor, Professor of the Department of Normal Physiology
Andijan, 170127, Atabekov str., 1
N. D. Ashuralieva
Andijan State Medical Institute (ASMI)
Uzbekistan
Uzbekistan
Nilufar D. kizi. Ashuralieva, Assistant of the Department of Propaedeutics of Internal Diseases, Faculty of medicine
Andijan, 170127, Atabekov str., 1
D. S. Kholikova
Andijan State Medical Institute (ASMI)
Uzbekistan
Uzbekistan
Dilrabo S. Kholikova, Assistant of the Department of Propaedeutics of Internal Diseases, Faculty of medicine
Andijan, 170127, Atabekov str., 1
References
1. Aleynik V.A., Babich S. M. [The effect of various doses of trypsin on the change in liver utilization of pentagastrin]. Vestnik TMA – Bulletin of TMA, 2013, no. 1, pp. 13–16. (in Russ.)
2. Aleynik V.A., Babich S. M. [The effect of pancreatic proteolytic and non-proteolytic hydrolases on the change in liver utilization of pentagastrin]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2013, no.5, pp.20–23. (in Russ.)
3. Aleynik V.A., Babich S. M. [Change in pancreatic secretion with the introduction of various doses of trypsin into the peripheral and portal veins]. Jurnalteoreticheskoy I klinicheskoy medicine – Journal of Theoretical and Clinical Medicine, 2012, no.4, pp.9–12. (in Russ.)
4. Babich S.M., Aleynik V. A. [Changes in gastric secretion when pentagastrin and leu-enkephalin are introduced into the peripheral and portal veins]. Journal of vrach-aspirant, Voronej – Journal Postgraduate Student, Voronezh, 2010, no. 5,2 (42), pp.252–257. (in Russ.)
5. AndreevaYu.V. [The effect of fasting and resumption of feeding on the secretory function of the stomach. Candidate biol. Sci. diss.]. St. Petersburg, 2007, 140 p. (in Russ.)
6. Smelisheva L. N. [Secretory function of the stomach and pancreas under the influence of emotional stress. Candidate med. sci. diss.]. Tyumen, 2007, 278 p. (in Russ.)
7. Akere A., et al. Upper gastrointestinal endoscopy in patients with cirrhosis: spectrum and prevalence of lesions. Annals of tropical medicine and public health, 2016, Vol. 9, No.2, 112 P. (in Russ.)
8. Bhattacharyya R., et al. A prospective pilot study of the prevalence of pancreatic disease in patients with alcohol related liver disease using faecal elastase-1. Gut, 2011, Vol.60, Suppl 1, С. A238-A238.
9. Hoffmaster K.A., Zamek-Gliszczynski M.J., Pollack G. M., Brouwer K. L. Hepatobiliary disposition of the metabolically stable opioid peptide [D-Pen2, D-Pen5]-enkephalin (DPDPE): pharmacokinetic consequences of the interplay between multiple transport systems. J Pharmacol Exp Ther. 2004 Dec;311(3):1203–10. doi: 10.1124/jpet.104.070201.
10. Kalaitzakis E, Bjornsson E Hepatic encephalopathy in patients with liver cirrhosis: is there a role of malnutrition. World J Gastroenterol. 2008 Jun 7;14(21):3438–9. doi: 10.3748/wjg.14.3438.
11. Katakura Y., Yotsuyanagi H., Hashizume K., et al. Pancreatic involvement in chronic viral hepatitis. World J Gastroenterol. 2005 Jun 21;11(23):3508–13. doi: 10.3748/wjg.v11.i23.3508.
12. Mazaki-Tovi M., Segev G., Yas-Natan E., Lavy E. Serum gastrin concentrations in dogs with liver disorders. Vet Rec. 2012 Jul 7;171(1):19. doi: 10.1136/vr.100627.
13. Ramachandran R., Hollenberg M. D. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. Br J Pharmacol. 2008 Mar;153 Suppl 1(Suppl 1): S263–82. doi: 10.1038/sj.bjp.0707507.
14. Rehfeld J.F., Bundgaard J. R., Hannibal J., et al. The Cell-Specific Pattern of Cholecystokinin Peptides in Endocrine Cells Versus Neurons Is Governed by the Expression of Prohormone Convertases 1/3, 2, and 5/6. Endocrinology. 2008 Apr;149(4):1600–8. doi: 10.1210/en.2007–0278.
15. Valentini L., Schuetz T., Omar A., Gläser S., Kasim E., et al. Abnormal plasma peptide YY(3–36) levels in patients with liver cirrhosis. Nutrition. 2011 Sep;27(9):880–4. doi: 10.1016/j.nut.2010.12.013.
Review
For citations:
Zhuraeva M.A., Aleynik V.A., Ashuralieva N.D., Kholikova D.S. Effect of pentagastrin and gastrin-17 on the secretory function of the gastric glands. Experimental and Clinical Gastroenterology. 2021;(11):75-78. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-195-11-75-78
Views:
360
Email this article 